Determination of Capecitabine and Its Metabolites in Plasma of Egyptian Colorectal Cancer Patients
The incidence of colorectal cancer (CRC) is increasing worldwide. It has variable signs and symptoms starting from changes in bowel habit to nausea and vomiting. Chemotherapeutic agents are often prescribed in CRC such as Capecitabine (CCB) and 5-Fluorouracil (FU). CCB is the prodrug of FU in oral d...
Main Authors: | Sara Shamseldin, Liza Samir Botros, Salem Eid Salem, Sahar Abdel-Maksoud, Mohamed Zakaria Gad, Rasha Sayed Hanafi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Analytica |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-4532/4/4/29 |
Similar Items
-
Clinical pharmacokinetics of capecitabine and its metabolites in colorectal cancer patients
by: Saeed Alqahtani, et al.
Published: (2022-05-01) -
Effect of Tarantula cubensis alcohol extract and Capecitabin combine in Colorectal Cancer rats
by: Rahmi Canbar, et al.
Published: (2023-06-01) -
A Case of Long Partial Response to Combination Therapy of Bevacizumab and Capecitabine for Liver Metastases of Rectal Cancer
by: Atsushi Kawasaki, et al.
Published: (2011-01-01) -
Capecitabine versus 5-fluorouracil in colorectal cancer: where are we now?
by: Lakshmi Chintala, et al.
Published: (2011-06-01) -
Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study Based on a CRC Database
by: Qiao Yu, et al.
Published: (2023-01-01)